{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:55:21Z","timestamp":1781636121166,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Blood cancers are the third most common cancer in Australia. However, little is known about their diagnostic pathway in the Australian context. This research aimed to assess the interval between first primary health care (PHC) contact and first haematologist visit, and referrals to specialists other than haematologists (non-haematological referrals) during blood cancer diagnoses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An online national survey was conducted with patients living with blood cancers, such as leukaemia, lymphoma, multiple myeloma, myeloproliferative neoplasms (MPN) and myelodysplastic neoplasms (MDS) between October and November 2022. Univariate and adjusted logistic regression models were applied to examine sociodemographic factors (age, sex, income, residence location, country of birth, private health insurance) and type of blood cancers associated with extended PHC-haematologist visit intervals (&gt;\u20091-month) and non-haematological referrals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the total 1758 participants, 26.3% (95% CI 24.3, 28.4%) patients experienced an extended PHC-haematologist visit interval (&gt;\u20091-month) and of 1749 participants, 24.8% (95% CI 22.8, 26.9%) patients experienced non-haematological referrals during their diagnosis stage. Women were more likely to report an extended PHC-haematologist visit interval (adjusted odds ratio aOR 1.38, 95% CI 1.10, 1.73) or non-haematological referrals (aOR 1.42, 95%CI 1.12, 1.80). Regional Australians (aOR 1.37, 95%CI 1.08, 1.73) were more likely to experience an extended PHC -haematologist visit interval, but the odds of non-haematological referrals was not significant for them. Being older (\u2265\u200965 years) (aOR 0.59, 95% CI 0.36, 0.97) and overseas-born (aOR 0.73, 95%CI 0.54, 0.99) were associated with a lower likelihood of non-haematological referrals. Private insurance holders (aOR 1.19, 95% CI 1.05, 1.35) were also more likely to have specialist referrals other than haematologists. Patients with an indolent type of blood cancers, such as lymphomas, multiple myeloma and MDS, are more likely to experience an extended PHC-haematologist visit interval or non-haematological referrals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A multi-pronged approach, including raising awareness of blood cancer signs and symptoms among both patients and health care professionals and improving access to GPs and specialist services, particularly in regional and rural Australia, is required to improve timely help-seeking during diagnosis. More evidence is also needed on clusters of non-specific symptoms indicative of haematological cancers underpinning guidelines and optimal care pathways to support possible use of automated software prompts and prompt diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-15757-1","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:56:32Z","timestamp":1771325792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Time to haematologist visit and non-haematological referral from primary health care during blood cancer diagnosis \u2013 findings from a large national survey in Australia"],"prefix":"10.1186","volume":"26","author":[{"given":"Mohammad Radwanur","family":"Talukder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Kovacev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Stavreski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"DeLacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"15757_CR1","unstructured":"National Cancer Institute. NCI Dictionary of Cancer Terms 2025. Available from: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/hematologic-cancer"},{"issue":"1","key":"15757_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","volume":"13","author":"N Zhang","year":"2023","unstructured":"Zhang N, Wu J, Wang Q, Liang Y, Li X, Chen G, et al. Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J. 2023;13(1):82.","journal-title":"Blood Cancer J"},{"issue":"1","key":"15757_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40164-025-00684-x","volume":"14","author":"T Pan","year":"2025","unstructured":"Pan T, Zhang J, Wang X, Song Y. Global burden and trends of hematologic malignancies based on global cancer observatory 2022 and global burden of disease 2021. Exp Hematol Oncol. 2025;14(1):98.","journal-title":"Exp Hematol Oncol"},{"key":"15757_CR4","unstructured":"Leukaemia F. Insight Economics. State of the nation: blood cancers in Australia 2023. Report; 2023."},{"key":"15757_CR5","unstructured":"Leukaemia F. & Insight Economics. State of the Nation: Blood Cancers in Australia 2019. 2019."},{"key":"15757_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1472-6963-8-49","volume":"8","author":"RP Hansen","year":"2008","unstructured":"Hansen RP, Olesen F, Sorensen HT, Sokolowski I, Sondergaard J. Socioeconomic patient characteristics predict delay in cancer diagnosis: a Danish cohort study. BMC Health Serv Res. 2008;8:49.","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"15757_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1258\/jhsrp.2011.010113","volume":"17","author":"F Walter","year":"2012","unstructured":"Walter F, Webster A, Scott S, Emery J. The Andersen model of total patient delay: a systematic review of its application in cancer diagnosis. J Health Serv Res Policy. 2012;17(2):110\u20138.","journal-title":"J Health Serv Res Policy"},{"key":"15757_CR8","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1017\/S1463423623000129","volume":"24","author":"GB Black","year":"2023","unstructured":"Black GB, Boswell L, Harris J, Whitaker KL. What causes delays in diagnosing blood cancers? A rapid review of the evidence. Prim Health Care Res Dev. 2023;24:e26.","journal-title":"Prim Health Care Res Dev"},{"issue":"4","key":"15757_CR9","doi-asserted-by":"publisher","first-page":"e0194788","DOI":"10.1371\/journal.pone.0194788","volume":"13","author":"DA Howell","year":"2018","unstructured":"Howell DA, Hart RI, Smith AG, Macleod U, Patmore R, Cook G, et al. Myeloma: patient accounts of their pathways to diagnosis. PLoS ONE. 2018;13(4):e0194788.","journal-title":"PLoS ONE"},{"issue":"1Suppl 1","key":"15757_CR10","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1038\/bjc.2015.40","volume":"112","author":"G Lyratzopoulos","year":"2015","unstructured":"Lyratzopoulos G, Saunders CL, Abel GA, McPhail S, Neal RD, Wardle J, et al. The relative length of the patient and the primary care interval in patients with 28 common and rarer cancers. Br J Cancer. 2015;112(1Suppl 1):S35\u201340.","journal-title":"Br J Cancer"},{"issue":"1","key":"15757_CR11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12885-019-5586-4","volume":"19","author":"K Antel","year":"2019","unstructured":"Antel K, Levetan C, Mohamed Z, Louw VJ, Oosthuizen J, Maartens G, et al. The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting. BMC Cancer. 2019;19(1):384.","journal-title":"BMC Cancer"},{"key":"15757_CR12","doi-asserted-by":"crossref","unstructured":"Zorlu T, Kayer MA, Okumus N, Ulas T, Dal MS, Altuntas F. Challenges, Difficulties, and delayed diagnosis of multiple myeloma. Diagnostics (Basel). 2025 Jul 4;15(13): 1708.","DOI":"10.3390\/diagnostics15131708"},{"key":"15757_CR13","doi-asserted-by":"crossref","unstructured":"Dapkeviciute A, Sapoka V, Martynova E, Peceliunas V. Time from symptom onset to diagnosis and treatment among haematological malignancies: influencing factors and associated negative outcomes. Medicina . 2019;55(6) :238.","DOI":"10.3390\/medicina55060238"},{"issue":"1","key":"15757_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2052-1839-13-9","volume":"13","author":"DA Howell","year":"2013","unstructured":"Howell DA, Smith AG, Jack A, Patmore R, Macleod U, Mironska E, et al. Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the haematological malignancy research network. BMC Hematol. 2013;13(1):9.","journal-title":"BMC Hematol"},{"issue":"10","key":"15757_CR15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/qjmed\/hcm077","volume":"100","author":"CC Kariyawasan","year":"2007","unstructured":"Kariyawasan CC, Hughes DA, Jayatillake MM, Mehta AB. Multiple myeloma: causes and consequences of delay in diagnosis. QJM. 2007;100(10):635\u201340.","journal-title":"QJM"},{"key":"15757_CR16","unstructured":"Australian Academy of Science & Australian Academy of Health and Medical Science. RESEARCH ROADMAP FOR BLOOD CANCER. 2024."},{"key":"15757_CR17","unstructured":"Cancer Council. Optimal Care Pathways 2025. Available from: https:\/\/www.cancer.org.au\/health-professionals\/optimal-cancer-care-pathways"},{"key":"15757_CR18","unstructured":"National Institute for Health and Care Excellence (NICE). Suspected cancer: recognition and referral (NG12) 2025. Available from: https:\/\/www.nice.org.uk\/guidance\/ng12"},{"key":"15757_CR19","unstructured":"Department of Health DaA. Modified Monash Model 2025 [Available from: https:\/\/digital.atlas.gov.au\/datasets\/digitalatlas::modified-monash-model\/about"},{"issue":"5","key":"15757_CR20","doi-asserted-by":"publisher","first-page":"e0127717","DOI":"10.1371\/journal.pone.0127717","volume":"10","author":"NU Din","year":"2015","unstructured":"Din NU, Ukoumunne OC, Rubin G, Hamilton W, Carter B, Stapley S, et al. Age and gender variations in cancer diagnostic intervals in 15 cancers: analysis of data from the UK clinical practice research datalink. PLoS ONE. 2015;10(5):e0127717.","journal-title":"PLoS ONE"},{"key":"15757_CR21","doi-asserted-by":"publisher","first-page":"104427","DOI":"10.1016\/j.breast.2025.104427","volume":"80","author":"LA Hoveling","year":"2025","unstructured":"Hoveling LA, Schuurman M, Siesling S, van Asselt KM, Bode C. Diagnostic delay in women with cancer: what do we know and which factors contribute? Breast. 2025;80:104427.","journal-title":"Breast"},{"issue":"1","key":"15757_CR22","first-page":"85","volume":"24","author":"CL Saunders","year":"2015","unstructured":"Saunders CL, Abel GA, Lyratzopoulos G. Inequalities in reported cancer patient experience by socio-demographic characteristic and cancer site: evidence from respondents to the english cancer patient experience survey. Eur J Cancer Care (Engl). 2015;24(1):85\u201398.","journal-title":"Eur J Cancer Care (Engl)"},{"key":"15757_CR23","doi-asserted-by":"crossref","unstructured":"Nuno-Solinis R, Urtaran-Laresgoiti M, Lazaro E, Ponce S, Orueta JF, Errea Rodriguez M. Inequalities in health care experience of patients with chronic conditions: results from a Population-Based study. Healthc (Basel). 2021 Aug 5;9(8) :1005.","DOI":"10.3390\/healthcare9081005"},{"key":"15757_CR24","doi-asserted-by":"publisher","first-page":"e391516","DOI":"10.1200\/EDBK_391516","volume":"43","author":"BP Keenan","year":"2023","unstructured":"Keenan BP, Barr E, Gleeson E, Greenberg CC, Temkin SM. Structural sexism and cancer care: the effects on the patient and oncologist. Am Soc Clin Oncol Educ Book. 2023;43:e391516.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1","key":"15757_CR25","doi-asserted-by":"publisher","first-page":"21477","DOI":"10.1038\/s41598-020-78517-6","volume":"10","author":"E Foroozani","year":"2020","unstructured":"Foroozani E, Ghiasvand R, Mohammadianpanah M, Afrashteh S, Bastam D, Kashefi F, et al. Determinants of delay in diagnosis and end stage at presentation among breast cancer patients in iran: a multi-center study. Sci Rep. 2020;10(1):21477.","journal-title":"Sci Rep"},{"issue":"9","key":"15757_CR26","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1111\/imj.70138","volume":"55","author":"Z Otty","year":"2025","unstructured":"Otty Z, Larkins S, Evans R, Brown A, Sabesan S. Improving the timeliness of care for regional lung cancer patients through the implementation of a web-based lung cancer referral pathway. Intern Med J. 2025;55(9):1474\u201382.","journal-title":"Intern Med J"},{"key":"15757_CR27","first-page":"100158","volume":"11","author":"M Baazeem","year":"2024","unstructured":"Baazeem M, Kruger E, Tennant M. Current status of tertiary healthcare services and its accessibility in rural and remote australia: A systematic review. Health Sci Rev. 2024;11:100158.","journal-title":"Health Sci Rev"},{"key":"15757_CR28","unstructured":"National Rural Health Alliance. RURAL HEALTH IN AUSTRALIA SNAPSHOT 2025. 2025."},{"issue":"7","key":"15757_CR29","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/jnci\/djac030","volume":"114","author":"S Bhatia","year":"2022","unstructured":"Bhatia S, Landier W, Paskett ED, Peters KB, Merrill JK, Phillips J, et al. Rural-Urban disparities in cancer outcomes: opportunities for future research. J Natl Cancer Inst. 2022;114(7):940\u201352.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"15757_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12875-020-01341-4","volume":"22","author":"KM Glenister","year":"2021","unstructured":"Glenister KM, Guymer J, Bourke L, Simmons D. Characteristics of patients who access zero, one or multiple general practices and reasons for their choices: a study in regional Australia. BMC Fam Pract. 2021;22(1):2.","journal-title":"BMC Fam Pract"},{"key":"15757_CR31","unstructured":"Breadon P, Geraghty J, Jones D, Baldwin E. Special treatment: improving australians\u2019 access to specialist care. Grattan Institute; 2025. https:\/\/grattan.edu.au\/wp-content\/uploads\/2025\/06\/Grattan-Institute-Special-Treatment.pdf"},{"issue":"6","key":"15757_CR32","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.annonc.2020.02.018","volume":"31","author":"M Heuser","year":"2020","unstructured":"Heuser M, Ofran Y, Boissel N, Brunet Mauri S, Craddock C, Janssen J, et al. Acute myeloid leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(6):697\u2013712.","journal-title":"Ann Oncol"},{"issue":"12","key":"15757_CR33","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H Dohner","year":"2022","unstructured":"Dohner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377.","journal-title":"Blood"},{"issue":"739","key":"15757_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3399\/bjgp24X736149","volume":"74","author":"W Hamilton","year":"2024","unstructured":"Hamilton W. Leukaemia diagnosis and primary care. Br J Gen Pract. 2024;74(739):54\u20135.","journal-title":"Br J Gen Pract"},{"issue":"679","key":"15757_CR35","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.3399\/bjgp19X701009","volume":"69","author":"DA Howell","year":"2019","unstructured":"Howell DA, Hart RI, Smith AG, Macleod U, Patmore R, Roman E. Disease-related factors affecting timely lymphoma diagnosis: a qualitative study exploring patient experiences. Br J Gen Pract. 2019;69(679):e134\u201345.","journal-title":"Br J Gen Pract"},{"issue":"634","key":"15757_CR36","doi-asserted-by":"publisher","first-page":"e281","DOI":"10.3399\/bjgp15X684793","volume":"65","author":"EA Shephard","year":"2015","unstructured":"Shephard EA, Neal RD, Rose PW, Walter FM, Hamilton WT. Quantifying the risk of non-Hodgkin lymphoma in symptomatic primary care patients aged >\/=40 years: a large case-control study using electronic records. Br J Gen Pract. 2015;65(634):e281\u20138.","journal-title":"Br J Gen Pract"},{"issue":"631","key":"15757_CR37","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.3399\/bjgp15X683545","volume":"65","author":"EA Shephard","year":"2015","unstructured":"Shephard EA, Neal RD, Rose P, Walter FM, Litt EJ, Hamilton WT. Quantifying the risk of multiple myeloma from symptoms reported in primary care patients: a large case-control study using electronic records. Br J Gen Pract. 2015;65(631):e106\u201313.","journal-title":"Br J Gen Pract"},{"key":"15757_CR38","unstructured":"YouGov. Blood cancer equity and access 2024. Available from: https:\/\/www.leukaemia.org.au\/media\/australians-at-risk\/#refs"},{"key":"15757_CR39","doi-asserted-by":"publisher","first-page":"i5515","DOI":"10.1136\/bmj.i5515","volume":"355","author":"BD Nicholson","year":"2016","unstructured":"Nicholson BD, Mant D, Bankhead C. Can safety-netting improve cancer detection in patients with vague symptoms? BMJ. 2016;355:i5515.","journal-title":"BMJ"},{"issue":"19","key":"15757_CR40","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1080\/14796694.2025.2525016","volume":"21","author":"B Russell","year":"2025","unstructured":"Russell B, Monroy-Iglesias MJ, Moss CL, Van Hemelrijck M, Weild S, Fabris E, et al. A real-world evaluation of the rapid diagnostic clinic roll out in South East London. Future Oncol. 2025;21(19):2451\u20138.","journal-title":"Future Oncol"},{"key":"15757_CR41","doi-asserted-by":"publisher","first-page":"1606243","DOI":"10.3389\/ijph.2024.1606243","volume":"69","author":"A Wale","year":"2024","unstructured":"Wale A, Okolie C, Everitt J, Hookway A, Shaw H, Little K, et al. The effectiveness and Cost-Effectiveness of community diagnostic centres: A rapid review. Int J Public Health. 2024;69:1606243.","journal-title":"Int J Public Health"},{"issue":"3","key":"15757_CR42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/17557380211065775","volume":"15","author":"E Hyde-Nero","year":"2022","unstructured":"Hyde-Nero E, Smith S, Martin C, York N. Diagnosing leukaemia in a primary health care setting. InnovAiT. 2022;15(3):165\u201370.","journal-title":"InnovAiT"},{"key":"15757_CR43","unstructured":"Cancer Council WA. Find cancer early 2025. Available from: https:\/\/www.findcancerearly.com.au\/"},{"issue":"1","key":"15757_CR44","doi-asserted-by":"publisher","first-page":"e2141633","DOI":"10.1001\/jamanetworkopen.2021.41633","volume":"5","author":"V Giannakeas","year":"2022","unstructured":"Giannakeas V, Kotsopoulos J, Cheung MC, Rosella L, Brooks JD, Lipscombe L, et al. Analysis of platelet count and new cancer diagnosis over a 10-Year period. JAMA Netw Open. 2022;5(1):e2141633.","journal-title":"JAMA Netw Open"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15757-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15757-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15757-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:22:38Z","timestamp":1781634158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15757-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15757"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15757-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and a waiver of individual informed consent for secondary analysis of de-identified data obtained from the Greater Western Human Research Ethics Committee (HREC 2024\/ETH02670) in compliance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"300"}}